Abstract
Medulloblastoma is a common tumor of the posterior fossa, representing 20-25% of all pediatric neoplasms. It commonly occurs in the midline (cerebellar vermis) and rarely at the cerebellopontine angle. Most of them are intra-axial, and an extra-axial location of this tumor is very rare. Extra-axial cerebellopontine angle medulloblastoma is extremely uncommon and has never been reported in an infant. We report an extra-axial cerebellopontine angle medulloblastoma in a 1-year-old child.
References
1.
Mueller DP, Moore SA, Sato Y, Yuh WT: MRI spectrum of medulloblastoma. Clin Imaging 1992;16:250-255.
2.
Fallah A, Banglawala SM, Provias J, Jha NK: Extra-axial medulloblastoma in the cerebellopontine angle. Can J Surg 2009;52:E101-E102.
3.
Mohan M, Pande A, Vasudevan MC, Ramamurthi R: Pediatric medulloblastoma: a review of 67 cases at a single institute. Asian J Neurosurg 2008;2:63-69.
4.
Kumar R, Bhowmick U, Kalra SK, Mahapatra AK. Pediatric cerebellopontine angle medulloblastomas. J Pediatr Neurosci 2008;3:127-130.
5.
Meghana C, Santosh P: An extraaxial cerebello-pontine angle medulloblastoma in a 56 year old male - a rare case report. Int J Sci Res 2016;5:822-823.
6.
Cugati G, Singh M, Symss NP, Pande A, Vasudevan MC, Ramamurthi R: Extra axial cerebellopontine angle medulloblastoma - a rare site of tumor. Indian J Med Paediatr Oncol 2011;32:123-124.
7.
Bahrami E, Bakhti S, Fereshtehnejad SM, Parvaresh M, Khani MR: Extra-axial medulloblastoma in cerebello-pontine angle: a report of a rare case with literature review. Med J Islam Repub Iran 2014;28:57.
8.
Singh M, Cugati G, Symss NP, Pande A, Vasudevan MC, Ramamurthi R: Extra axial adult cerebellopontine angle medulloblastoma: an extremely rare site of tumor with metastasis. Surg Neurol Int 2011;2:25.
9.
Gil-Salu JL, Rodriguez-Pena F, Lopez-Escobar M, Palomo MJ. Medulloblastoma presenting as an extra-axial tumour in the cerebellopontine angle. Neurocirugia (Astur) 2004;15:285-289.
10.
Jaiswal AK, Mahapatra AK, Sharma MC: Cerebellopontine angle medulloblastoma. J Clin Neurosci 2004;11:42-45.
11.
Raaf J, Kernohan JW: Relation of abnormal collections of cells in posterior medullary velum of cerebellum to origin of medulloblastoma. Arch Neurol Psychiatry 1944;52:163-169.
12.
Stevenson L, Echlim F: Nature and origin of some tumors of cerebellum: medullobastoma. Arch Neurol Psychiatry 1934;31:93-109.
13.
Kadin ME, Rubinstein LJ: Neonatal cerebellar medulloblastoma originating from fetal external granular layer. J Neuropathol Exp Neurol 1970;29:583-599.
14.
Kernohan JW, Woltman HW, Adson AW: Gliomas of the cerebellopontine angle. J Neuropathol Exp Neurol 1948;7:349-367.
15.
Ringertz N, Tola JH: Medulloblastomas. J Neuropathol Exp Neurol 1950;9:354-372.
16.
Park TS, Hoffman HJ, Hendrick EB, et al: Medulloblastoma: clinical presentation and management. J Neurosurg 1983;58:543-552.
17.
Chan AW, Tarbell NJ, Black PM, Louis DN, Frosch MP, Ancukiewicz M, et al: Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 2000;47:623-631.
18.
Moffat DA, Saunders JE, McElveen JT Jr, McFerran DJ, Hardy DG: Unusual cerebello-pontine angle tumours. J Laryngol Otol 1993;107:1087-1098.
19.
Dhellemmes P, Demaille MC, Lejeune JP, Baranzelli MC, Combelles G, Torrealba G: Cerebellar medulloblastoma: results of multidisciplinary treatment. Report of 120 cases. Surg Neurol 1986;25:290-294.
20.
Winn HR, Berger MS, Dacey RG Jr (eds): Youmans Neurological Surgery, ed 6. Philadelphia, Elsevier, 2011, vol 2, p 1353.
21.
Britton BH: Adult medulloblastoma, neuro-otological manifestations. Ann Otol 1975;84:364-367.
22.
Mehta JS, Sharma MM: An unusual case acute labyrinthine failure. J Laryngol Otol 1998;112:193-195.
23.
Corden BJ, et al: Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors. J Neurol Oncol 1991;11:57-63.
24.
Akay KM, Erdogan E, Izci Y, Kaya A, Timurkaynak E: Medulloblastoma of the cerebellopontine angle - case report. Neurol Med Chir (Tokyo) 2003;43:555-558.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.